The dose ladder,week by week.
A typical tirzepatide titration, what each rung is for, and why climbing it is never automatic. Your clinician sets your own schedule, and holding or lowering a dose is a normal clinical decision rather than a setback.
Weeks 1–4
2.5 mg
Not a treatment dose
This dose exists to let your gut adapt, not to move the scale. Some people lose weight on it and some do not, and neither tells you much about where you will end up.
Weeks 5–8
5 mg
The first therapeutic dose
Appetite suppression usually becomes obvious here. For a meaningful number of people this is where they stay, because it is enough.
Weeks 9–12
7.5 mg
Only if needed
Increased only if your response has stalled and you are tolerating the current dose well. Going up is not automatic and it is not a reward.
Weeks 13–16
10 mg
Only if needed
The same test applies. If you are still losing steadily, there is no clinical reason to climb, and climbing costs you tolerability for nothing.
Week 17 onward
12.5–15 mg
The ceiling, for some
The maximum studied dose. Plenty of people never reach it and never need to. Reaching it is not a measure of commitment.
Four of those five steps are optional. The right dose is the lowest one that is still working for you.
Illustrative of a common schedule and not a plan you are entitled to. Which medication you are prescribed, at what dose, and how quickly it changes are clinical decisions made after your evaluation and reviewed as you respond. A prescription is never guaranteed in advance.
That is the whole ladder
You have now read further into the dosing than most people get before they start,which is rather the point.
About three minutes. Nothing is prescribed at this step and nothing is charged.